Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions. Coming after four years of ...

Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...

The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine, Nuvaxovid, but only for limited use in ...

53. WASHINGTON — Food and Drug Administration Commissioner Marty Makary said the agency is planning to unveil new guidance for vaccine makers, focused primarily on Covid-19 shots, in the coming ...

particularly COVID-19 shots. “We want to be very transparent, and we want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to ...

Califf also expressed concern over reports that political appointees halted the full approval of Novavax’s Covid-19 vaccine, saying that FDA scientists should be shielded from any political ...

"The COVID-19 vaccine development process was driven by science and guided by the U.S. FDA back in 2020," said Rose. "Theories to the contrary are simply untrue and being manufactured." The ...

Kennedy Jr. The White House previously introduced changes to the traditional process of approving updated coronavirus vaccines ... so they have a predictable FDA where they don’t have to ...